Skip to main
AARD
AARD logo

AARD Earnings Dates & Reports

AARD Most Recent Earnings

Report DateAug 12, 2025
Period EndingQ2 2025
Est. EPS-$0.57
Actual EPS-$0.66
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

AARD Earnings per Share (EPS) History

Signup for full access
Browse free

AARD Latest Earnings

The value each AARD share was expected to gain vs. the value each share gained.

AARD reported its most recent earnings on Aug 12, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.66. This exceeded analysts' expectations of -$0.57 by 15.79%, marking a Miss.

For comparison, Aardvark Therapeutics Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 11/14/2025, with analysts projecting an EPS of -$0.75.

AARD Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 13, 2025
-$0.75Next earnings call Nov. 14, 2025
Q2 2025Aug 12, 2025
-$0.57-$0.66+15.79%

AARD Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Aardvark Therapeutics Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 13, 2025

AARD Earnings FAQs

AARD last reported earnings on Aug 12, 2025 for Q2 2025, posting an EPS of -$0.66, which Miss the estimate of -$0.57 by 15.79%.

For Q2 2025, AARD reported an EPS of -$0.66, missing analysts' estimate of -$0.57 by 15.79%.

For Q2 2025, AARD Miss expectations with an actual EPS of -$0.66 vs. an estimated EPS of -$0.57.

Following the last earnings report on Aug 12, 2025, AARD's stock price moved — from — to —.

The next AARD earnings call is scheduled for Nov. 14, 2025, where executives will discuss financial results and outlook.

Aardvark Therapeutics Inc (AARD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.